Today: 7 February 2026
Subscribe
Browse Category

NASDAQ:PLAB News 10 December 2025 - 8 January 2026

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 08.01.2026

Royalty Pharma closed at $40.26, up 40% in a year, but a DCF model values shares at $179.83, about 77.6% higher. Camping World Holdings ended at $11.16, with a DCF value of $3.85, suggesting a 190% premium. Photronics traded at $31.78 after a 23.7% monthly gain; DCF analysis estimates intrinsic value at $19.02. Tanger raised $200 million in exchangeable notes and secured $550 million in term loans.
8 January 2026
···
Photronics (PLAB) Stock Soars 45% After Q4 Earnings Beat: AI Photomask Demand Resets the 2026 Outlook

Photronics (PLAB) Stock Soars 45% After Q4 Earnings Beat: AI Photomask Demand Resets the 2026 Outlook

Photronics, Inc. (NASDAQ: PLAB) has just turned into one of the hottest names in semiconductor equipment. After reporting better‑than‑expected fiscal Q4 2025 results and issuing bullish guidance for the start of fiscal 2026, the photomask specialist’s stock jumped about 45% to $37.35, its highest close since 2001 and its biggest single‑day gain since 2008. Barron’s The move not only blasted Photronics through prior resistance levels, it also pushed the share price above the average Wall Street 12‑month target, forcing investors and analysts to rethink what PLAB is worth in an AI‑driven chip cycle. Nasdaq+1 Photronics stock today: Where PLAB stands
11 December 2025
··
Top U.S. Stock Gainers After the Bell on December 10, 2025: ASPC, BBGI, ENVB, PLAB, IRBT, AHT Lead Fed‑Day Rally

Top U.S. Stock Gainers After the Bell on December 10, 2025: ASPC, BBGI, ENVB, PLAB, IRBT, AHT Lead Fed‑Day Rally

New York – December 10, 2025 — Wall Street closed higher on Wednesday after the Federal Reserve delivered its third interest‑rate cut of 2025, lifting the Dow, S&P 500 and Nasdaq and setting the stage for a powerful “stock picker’s” session beneath the surface. Reuters+1 While the major indices moved less than 1% each, a cluster of small‑ and mid‑cap names exploded higher by 40–390% during regular trading, with several of them still among the biggest movers in after‑hours trading. According to StockAnalysis, the top 10 U.S. gainers by percentage at the close were dominated by micro‑caps, speculative biotech, and
10 December 2025
········
Photronics (PLAB) Stock Soars Over 40% on Q4 2025 Earnings Beat and Bullish 2026 Outlook

Photronics (PLAB) Stock Soars Over 40% on Q4 2025 Earnings Beat and Bullish 2026 Outlook

Photronics, Inc. (NASDAQ: PLAB) — a specialist in photomasks for semiconductors and flat-panel displays — has suddenly become one of the hottest tickers in the semiconductor supply chain. After reporting stronger‑than‑expected fourth‑quarter and full‑year fiscal 2025 results on December 10, 2025, Photronics stock exploded more than 40% in a single session, driven by an earnings beat, upbeat guidance, and a wave of bullish options activity. GlobeNewswire+1 Below is a detailed look at today’s news, Wall Street forecasts, and the key debates now forming around PLAB stock. Photronics stock today: a rare 40%+ melt‑up Photronics shares closed near $25.7 on December
10 December 2025
··

Stock Market Today

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

7 February 2026
MARA shares jumped 22.4% to $8.24 Friday, trading higher after hours, as the company moved $87 million in bitcoin to major custodians. About 82.4 million MARA shares changed hands. Bitcoin hovered near $68,928 Saturday. A MARA filing showed its general counsel had shares withheld for taxes on vested stock units, not an open market sale.
Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

7 February 2026
Apple shares closed up 0.8% at $278.12 Friday, then slipped 0.3% after hours. A global DRAM shortage is raising component costs, putting pressure on Apple’s pricing ahead of its Feb. 24 shareholder meeting. CEO Tim Cook said memory prices will rise “sharply” but gave no details on possible iPhone price hikes. Investors await signals before next week’s U.S. inflation data.
Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
Go toTop